Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03808818 · ClinicalTrials.gov registry record · NA
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices
A NA study, sponsored by ECOG-ACRIN Cancer Research Group.
- Completed
- Registry status
- NA
- Development phase
- 306
- Enrollment target
NCT03808818: Completed NA study, sponsored by ECOG-ACRIN Cancer Research Group.
NCT03808818 is a NA study that has completed, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 306 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03808818, a NA study, has completed, sponsored by ECOG-ACRIN Cancer Research Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
Study Summary
This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.
Primary Outcome
We will define 7-day point-prevalence by saliva cotinine (\< 15 ng/ml) or expired air CO (\<10 ppm). All participants who report being quit and no NRT or e-cigarette use will be requested to provide saliva samples, expired air CO will be measured in participants who report being quit and report concurrent NRT or e-cigarette use. If a participant is lost to follow-up or does not provide a saliva or CO sample, they will be considered a current smoker. COVID-19 restrictions prevented any saliva or
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Survey Administration
- DRUG Nicotine Replacement
- OTHER Tobacco Cessation Counseling
- OTHER Behavioral, Psychological or Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT03808818 record still lists
NCT03808818 is an interventional study that assigns participants to a tested intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03808818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03808818 about?
NCT03808818 is a clinical study titled "Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices". This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.
What is the current status of trial NCT03808818?
This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2019-08-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03808818?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Nicotine Replacement (DRUG), Tobacco Cessation Counseling (OTHER), Behavioral, Psychological or Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT03808818?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03808818's enrollment target sits among peer trials
306 324th of 2000 higher than 1,674 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI